prednisolone has been researched along with Diabetes Mellitus, Adult-Onset in 56 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with prednisolone at both dosages reduced CRP levels significantly." | 6.77 | Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. ( Bijlsma, JW; den Uyl, D; Diamant, M; Dijkmans, BA; Hoes, JN; Lems, WF; Nurmohamed, MT; van Raalte, DH, 2012) |
| "Men with the metabolic syndrome but without diabetes received prednisolone 30 mg once daily plus sitagliptin 100 mg once daily (n=14), prednisolone (n=12) or sitagliptin alone (n=14) or placebo (n=12) for 14 days in a double-blind 2 × 2 randomized-controlled study." | 5.19 | Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial. ( Diamant, M; Heymans, MW; Mari, A; Muskiet, MH; Ouwens, DM; Pouwels, PJ; van Genugten, RE; van Raalte, DH, 2014) |
| " We sought to test the hypothesis that tapering of prednisolone (TAP) the first year after renal transplantation improves insulin sensitivity (IS), and to assess the effect of complete steroid withdrawal (SW) on IS in patients on a cyclosporine-based immunosuppressive regimen." | 5.11 | Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. ( Egeland, T; Hartmann, A; Hjelmesaeth, J; Jenssen, T; Lund, K; Midtvedt, K; Paulsen, D, 2004) |
| " The common symptoms, complications, comorbidities, and medications were fever, pneumonia, hypertension, and prednisolone, respectively." | 4.12 | Analysis of potential risk factors associated with COVID-19 and hospitalization. ( Alamri, AS; Aldhwayan, NI; Alharbi, AA; Alharbi, AM; Alharbi, NS; Alhomrani, M; Almohaimeed, AT; Almushayti, BK; Alsanie, WF; Asdaq, SMB; Halim Mohamed, AA; Rabbani, SI, 2022) |
| " She was being treated with tacrolimus, methotrexate and prednisolone for prophylaxis and treatment of graft-versus-host disease, and with intensive insulin therapy for better glycemic control." | 3.78 | Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation. ( Akashi, K; Fukagawa, S; Furue, M; Miyamoto, T; Moroi, Y; Sugiyama, A; Takeuchi, S; Yoshimoto, G, 2012) |
| "We report here the observation of a 60-year-old man who had an autoimmune pancreatitis revealed by a jaundice, in whom an insulin-treated diabetes mellitus, which was diagnosed one month before, completely resolved after the administration of prednisolone given to treat this symptomatic pancreatitis." | 3.76 | [Complete resolution of insulin-dependent diabetes mellitus in a patient with autoimmune pancreatitis following treatment with corticosteroids]. ( Dahan, M; de Mestier, L; Felce, M; Hammel, P; Hillaire, S; Lévy, P; Penfornis, A; Ruszniewski, P, 2010) |
| " The autoimmune hepatitis was treated with prednisolone (initially 60 mg daily, then reduced to 10 mg daily) and azathioprine (initially 100 mg daily, reduced to 50 mg daily)." | 3.69 | [Autoimmune hepatitis, autoimmune gastritis, hypergastrinemia and stomach carcinoid]. ( Ormann, W, 1995) |
| "Treatment with prednisolone at both dosages reduced CRP levels significantly." | 2.77 | Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. ( Bijlsma, JW; den Uyl, D; Diamant, M; Dijkmans, BA; Hoes, JN; Lems, WF; Nurmohamed, MT; van Raalte, DH, 2012) |
| "Treatment of prednisolone-induced hyperglycaemia should be directed at the postprandial period." | 2.77 | Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study. ( Ahern, MJ; Burt, MG; Petersons, CJ; Smith, MD; Stranks, SN; Willenberg, VM, 2012) |
| "We report a patient with sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) who presented with widespread nodal and extranodal involvement affecting the skin, orbits and nasal sinuses, complicated by the development of autoimmune haemolytic anaemia." | 2.41 | Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. ( Bunker, CB; Costello, C; Francis, N; Grabczynska, SA; Toh, CT, 2001) |
| "Past medical history includes type 2 diabetes mellitus, transient ischaemic attack, hypertension, non-alcoholic fatty liver disease, dyslipidaemia, osteoarthritis and active smoking." | 1.91 | Metastatic xanthogranulomatous pyelonephritis managed with immunosuppression. ( Chrysostomou, A; Daniell, J; Pedagogos, E, 2023) |
| "Overall, rates of incidence of type 2 diabetes were 12." | 1.72 | The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid-related and phenotypic groups. ( Adamsson Eryd, S; Ambery, P; Astbury, C; Berni, E; Brown, MN; Currie, CJ; Heywood, B; Hunt, P; Jenkins-Jones, S, 2022) |
| "COPD is a progressive inflammatory disease of the lungs, characterized by acute exacerbations that may lead to increased mortality." | 1.72 | A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD. ( Alston, M; Bazell, C; Caplen, M; Comellas, AP; Feigler, N; Hansen, D; Pollack, M; Pyenson, B; Sethi, S; Staresinic, A; Styczynski, J, 2022) |
| "However, in this case, the patient had type 2 diabetes and prednisolone resulted in persistently elevated blood glucose levels." | 1.72 | Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum. ( Hunter, H; Middleton, D; Mulholland, O, 2022) |
| "Oral prednisolone was subsequently administered after the discontinuation of linagliptin, and his symptom gradually disappeared." | 1.56 | Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01. ( Hata, K; Hibi, A; Hosokawa, N; Ishihara, Y; Kasahara, Y; Nakagawa, T, 2020) |
| "Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever." | 1.56 | Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. ( Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T, 2020) |
| "In immune-mediated inflammatory diseases, there is a lack of -estimates of glucocorticoid dose-response diabetes risk that consider changes in prescribed dose over time and disease activity." | 1.56 | Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. ( Mackie, SL; Pujades-Rodriguez, M; Wu, J, 2020) |
| "A 77-year-old man with type 2 diabetes was consulted due to aggravation of glycemic control." | 1.51 | Dramatic Improvement of Glycemic Control by Promptly Starting Steroid Therapy at an Early Stage of Autoimmune Pancreatitis in a Subject with Type 2 Diabetes. ( Anno, T; Irie, S; Kaku, K; Kaneto, H; Kawamoto, H; Kawasaki, F; Nakamura, J; Uji, E, 2019) |
| " Information on the dosage and timing of GC use was extracted." | 1.43 | Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. ( Abrahamowicz, M; Beauchamp, ME; Dixon, WG; Michaud, K; Movahedi, M; Pedro, S; Ray, DW, 2016) |
| "Psychological stress may contribute to type 2 diabetes but mechanisms are still poorly understood." | 1.42 | Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes. ( Carvalho, LA; Hackett, RA; Hamer, M; Lazzarino, AI; Steptoe, A; Urbanova, L, 2015) |
| "A 66-year-old man with type 2 diabetes on hemodialysis treatment was admitted due to poor glycemic control." | 1.42 | Severe Insulin-resistant Diabetes due to Insulin Antibodies Associated with Eosinophilia. ( Nagao, M; Nakajima, Y; Oikawa, S; Sugihara, H; Takaya, M; Takemitsu, S; Uchigata, Y, 2015) |
| "A 76-year-old man with a history of type 2 diabetes mellitus was admitted with cholangitis caused by cholangiocarcinoma." | 1.40 | IgA-dominant postinfectious glomerulonephritis associated with Escherichia coli infection caused by cholangitis. ( Aki, S; Aoyagi, M; Arai, Y; Hirasawa, S; Inaba, N; Kikuchi, H; Nagahama, K; Tamura, T; Tanaka, H; Yamamura, C, 2014) |
| "Since the initial description of Sweet's syndrome in 1964, many unusual cases have been described in the literature (associated with neoplasias or systemic diseases, concomitant pustular or bullous lesions, etc." | 1.37 | [Neutrophilic dermatosis of the hands]. ( Barbaud, A; Brajon, D; Cuny, JF; Schmutz, JL, 2011) |
| "Diabetic retinopathy was absent in 22 (69%) cases where 10 (31%) patients had background diabetic retinopathy." | 1.31 | Non-diabetic renal disease in patients with type 2 diabetes mellitus. ( Kumar, NS; Prakash, J; Sen, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.79) | 18.7374 |
| 1990's | 7 (12.50) | 18.2507 |
| 2000's | 13 (23.21) | 29.6817 |
| 2010's | 24 (42.86) | 24.3611 |
| 2020's | 11 (19.64) | 2.80 |
| Authors | Studies |
|---|---|
| Kitao, R | 1 |
| Fukumoto, T | 1 |
| Hashimoto, T | 1 |
| Izumi, K | 1 |
| Jimbo, H | 1 |
| Takemori, C | 1 |
| Nishigori, C | 1 |
| Ambery, P | 1 |
| Adamsson Eryd, S | 1 |
| Jenkins-Jones, S | 1 |
| Heywood, B | 1 |
| Berni, E | 1 |
| Brown, MN | 1 |
| Astbury, C | 1 |
| Hunt, P | 1 |
| Currie, CJ | 1 |
| Alharbi, AM | 1 |
| Rabbani, SI | 1 |
| Halim Mohamed, AA | 1 |
| Almushayti, BK | 1 |
| Aldhwayan, NI | 1 |
| Almohaimeed, AT | 1 |
| Alharbi, AA | 1 |
| Alharbi, NS | 1 |
| Asdaq, SMB | 1 |
| Alamri, AS | 1 |
| Alsanie, WF | 1 |
| Alhomrani, M | 1 |
| Bazell, C | 1 |
| Pollack, M | 1 |
| Comellas, AP | 1 |
| Sethi, S | 1 |
| Alston, M | 1 |
| Pyenson, B | 1 |
| Hansen, D | 1 |
| Caplen, M | 1 |
| Staresinic, A | 1 |
| Styczynski, J | 1 |
| Feigler, N | 1 |
| Mulholland, O | 1 |
| Middleton, D | 1 |
| Hunter, H | 1 |
| Chen, AX | 1 |
| Radhakutty, A | 1 |
| Zimmermann, A | 1 |
| Stranks, SN | 3 |
| Thompson, CH | 1 |
| Burt, MG | 3 |
| Daniell, J | 1 |
| Pedagogos, E | 1 |
| Chrysostomou, A | 1 |
| Hibi, A | 1 |
| Kasahara, Y | 1 |
| Ishihara, Y | 1 |
| Hata, K | 1 |
| Hosokawa, N | 1 |
| Nakagawa, T | 1 |
| Daneshpazhooh, M | 1 |
| Soori, T | 1 |
| Isazade, A | 1 |
| Noormohammadpour, P | 1 |
| Wu, J | 1 |
| Mackie, SL | 1 |
| Pujades-Rodriguez, M | 1 |
| Aung, TKK | 1 |
| Chuah, TY | 1 |
| Chua, MWJ | 1 |
| Palamuthusingam, D | 1 |
| Mantha, M | 1 |
| Dheda, S | 1 |
| Tillmann, FP | 1 |
| Schmitz, M | 1 |
| Rump, LC | 1 |
| Quack, I | 1 |
| Azevedo, A | 1 |
| Cotovio, P | 1 |
| Góis, M | 1 |
| Nolasco, F | 1 |
| Irie, S | 1 |
| Anno, T | 1 |
| Uji, E | 1 |
| Nakamura, J | 1 |
| Kawasaki, F | 1 |
| Kawamoto, H | 1 |
| Kaku, K | 1 |
| Kaneto, H | 1 |
| Fukuhara, A | 1 |
| Tanino, Y | 1 |
| Sato, S | 1 |
| Ishii, T | 1 |
| Nikaido, T | 1 |
| Kanazawa, K | 1 |
| Saito, J | 1 |
| Ishida, T | 1 |
| Kanno, M | 1 |
| Watanabe, T | 2 |
| Munakata, M | 1 |
| van Genugten, RE | 1 |
| van Raalte, DH | 2 |
| Muskiet, MH | 1 |
| Heymans, MW | 1 |
| Pouwels, PJ | 1 |
| Ouwens, DM | 1 |
| Mari, A | 1 |
| Diamant, M | 2 |
| Brady, V | 1 |
| Thosani, S | 1 |
| Zhou, S | 1 |
| Bassett, R | 1 |
| Busaidy, NL | 1 |
| Lavis, V | 1 |
| Kikuchi, H | 1 |
| Aoyagi, M | 1 |
| Nagahama, K | 1 |
| Yamamura, C | 1 |
| Arai, Y | 1 |
| Hirasawa, S | 1 |
| Aki, S | 1 |
| Inaba, N | 1 |
| Tanaka, H | 1 |
| Tamura, T | 1 |
| Liu, XX | 1 |
| Zhu, XM | 1 |
| Miao, Q | 1 |
| Ye, HY | 1 |
| Zhang, ZY | 1 |
| Li, YM | 1 |
| Carvalho, LA | 1 |
| Urbanova, L | 1 |
| Hamer, M | 1 |
| Hackett, RA | 1 |
| Lazzarino, AI | 1 |
| Steptoe, A | 1 |
| Drake, SM | 1 |
| Aguilar-Loza, NR | 1 |
| Esterman, A | 1 |
| Roberts, GW | 1 |
| Takaya, M | 1 |
| Nagao, M | 1 |
| Takemitsu, S | 1 |
| Nakajima, Y | 1 |
| Sugihara, H | 1 |
| Uchigata, Y | 1 |
| Oikawa, S | 1 |
| Movahedi, M | 1 |
| Beauchamp, ME | 1 |
| Abrahamowicz, M | 1 |
| Ray, DW | 1 |
| Michaud, K | 1 |
| Pedro, S | 1 |
| Dixon, WG | 1 |
| Iizuka, K | 1 |
| Kato, T | 1 |
| Mizuno, M | 1 |
| Takeda, J | 1 |
| Mordal, GC | 1 |
| Hammarström, C | 1 |
| Namtvedt, T | 1 |
| Savaj, S | 1 |
| Abdi, E | 1 |
| Nejadgashti, H | 1 |
| Eris, S | 1 |
| Prooshaninia, F | 1 |
| Ataipoor, Y | 1 |
| Ossareh, S | 1 |
| Abbasi, MA | 1 |
| Heidari, H | 1 |
| Saheb-Jamii, H | 1 |
| Ebrahimzadeh, K | 1 |
| Ghods, AJ | 1 |
| de Mestier, L | 1 |
| Dahan, M | 1 |
| Hammel, P | 1 |
| Hillaire, S | 1 |
| Felce, M | 1 |
| Penfornis, A | 1 |
| Lévy, P | 1 |
| Ruszniewski, P | 1 |
| Koulentaki, M | 1 |
| Chryssou, E | 1 |
| Coucoutsi, C | 1 |
| Koutroubakis, I | 1 |
| Sugiyama, A | 1 |
| Takeuchi, S | 1 |
| Fukagawa, S | 1 |
| Moroi, Y | 1 |
| Yoshimoto, G | 1 |
| Miyamoto, T | 1 |
| Akashi, K | 1 |
| Furue, M | 1 |
| den Uyl, D | 1 |
| Nurmohamed, MT | 1 |
| Lems, WF | 1 |
| Bijlsma, JW | 1 |
| Hoes, JN | 1 |
| Dijkmans, BA | 1 |
| Brajon, D | 1 |
| Cuny, JF | 1 |
| Barbaud, A | 1 |
| Schmutz, JL | 1 |
| Willenberg, VM | 1 |
| Petersons, CJ | 1 |
| Smith, MD | 1 |
| Ahern, MJ | 1 |
| Liu, YC | 1 |
| Chang, WL | 1 |
| Gau, JP | 1 |
| Chao, TC | 1 |
| Martínez-Martínez, MU | 1 |
| Martínez-Lozano, J | 1 |
| Abud-Mendoza, C | 1 |
| Rohrmeier, C | 1 |
| Koemm, N | 1 |
| Babilas, P | 1 |
| Prahs, P | 1 |
| Strutz, J | 1 |
| Buettner, R | 1 |
| Midtvedt, K | 1 |
| Hjelmesaeth, J | 1 |
| Hartmann, A | 1 |
| Lund, K | 1 |
| Paulsen, D | 1 |
| Egeland, T | 1 |
| Jenssen, T | 1 |
| Jacobson, PB | 1 |
| von Geldern, TW | 1 |
| Ohman, L | 1 |
| Osterland, M | 1 |
| Wang, J | 1 |
| Zinker, B | 1 |
| Wilcox, D | 1 |
| Nguyen, PT | 1 |
| Mika, A | 1 |
| Fung, S | 1 |
| Fey, T | 1 |
| Goos-Nilsson, A | 1 |
| Grynfarb, M | 1 |
| Barkhem, T | 1 |
| Marsh, K | 1 |
| Beno, DW | 1 |
| Nga-Nguyen, B | 1 |
| Kym, PR | 1 |
| Link, JT | 1 |
| Tu, N | 1 |
| Edgerton, DS | 1 |
| Cherrington, A | 1 |
| Efendic, S | 1 |
| Lane, BC | 1 |
| Opgenorth, TJ | 1 |
| Fassbender, WJ | 1 |
| Aizman, A | 1 |
| Johnson, MW | 1 |
| Olsen, TW | 1 |
| Ho, AC | 1 |
| Davis, JL | 1 |
| Stiefelhagen, P | 1 |
| Kanazawa, A | 1 |
| Haginomori, S | 1 |
| Takamaki, A | 1 |
| Nonaka, R | 1 |
| Araki, M | 1 |
| Takenaka, H | 1 |
| Courtney, R | 1 |
| Stewart, PM | 1 |
| Toh, M | 1 |
| Ndongo, MN | 1 |
| Calle, RA | 1 |
| Hirshberg, B | 1 |
| Apel, A | 1 |
| Campbell, I | 1 |
| Rootman, DS | 1 |
| Ormann, W | 1 |
| Hosker, JP | 1 |
| Burnett, MA | 1 |
| Matthews, DR | 1 |
| Turner, RC | 1 |
| Paterson, AJ | 1 |
| Lamey, PJ | 1 |
| Lewis, MA | 1 |
| Nolan, A | 1 |
| Rademaker, M | 1 |
| Messiaen, T | 1 |
| Dive, A | 1 |
| Delos, M | 1 |
| Installé, E | 1 |
| Maeda, Y | 1 |
| Tomura, S | 1 |
| Kato, K | 1 |
| Owada, A | 1 |
| Imai, K | 1 |
| Koyano, T | 1 |
| Shimokama, T | 1 |
| Shiigai, T | 1 |
| Kudoh, A | 1 |
| Ebina, M | 1 |
| Kudo, H | 1 |
| Matsuki, A | 1 |
| Umezawa, Y | 1 |
| Oyake, S | 1 |
| Oh-i, T | 1 |
| Nagae, T | 1 |
| Ishimaru, S | 1 |
| Miura, J | 1 |
| Kwaguchi, Y | 1 |
| Tanaka, Y | 1 |
| Ishii, A | 1 |
| Iwasaki, N | 1 |
| Takahashi, Y | 1 |
| Iwamoto, Y | 1 |
| Wiener, K | 1 |
| Grabczynska, SA | 1 |
| Toh, CT | 1 |
| Francis, N | 1 |
| Costello, C | 1 |
| Bunker, CB | 1 |
| Prakash, J | 1 |
| Sen, D | 1 |
| Kumar, NS | 1 |
| Kayanuma, K | 1 |
| Matsumoto, Y | 1 |
| Yomura, Y | 1 |
| Uono, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism and Beta-Cell Dysfunction in Males With the Metabolic Syndrome X: A Randomized, Placebo-controlled, Double-blind Intervention Study With a 2x2 Factorial Design[NCT00721552] | 82 participants (Actual) | Interventional | 2008-10-31 | Completed | |||
| Multicenter, Randomized, Controlled Clinical Trial Research Evaluating the Use of Combination Therapy of Glucocorticoids and Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis[NCT03525028] | 138 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisolone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis.
Topics: Databases, Factual; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Hyperglycemia; Incidence; Pr | 2014 |
Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Female; H | 2001 |
6 trials available for prednisolone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; F | 2014 |
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; | 2012 |
Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; D | 2012 |
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.
Topics: Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucocorticoids; Graft Rejection; H | 2004 |
Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Oral; Adolescent; Adult; Aminopyridines | 2008 |
Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Glucose Clamp Technique; Humans; Ins | 1993 |
48 other studies available for prednisolone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes.
Topics: Autoantibodies; Autoantigens; Collagen Type XVII; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV | 2021 |
The absolute risk of incident type 2 diabetes following exposure to systemic corticosteroids in selected steroid-related and phenotypic groups.
Topics: Adrenal Cortex Hormones; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Male; Prednisolone; Ret | 2022 |
Analysis of potential risk factors associated with COVID-19 and hospitalization.
Topics: COVID-19; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Hospitalization; Humans; Hyper | 2022 |
A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD.
Topics: Adrenal Cortex Hormones; Aged; Diabetes Mellitus, Type 2; Humans; Hypertension; Insurance Claim Revi | 2022 |
Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Female; Humans; Middle Aged; Negative-Pressure Wound Therap | 2022 |
Clinical determinants of insulin requirements during treatment of prednisolone-induced hyperglycaemia.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypergly | 2023 |
Metastatic xanthogranulomatous pyelonephritis managed with immunosuppression.
Topics: Diabetes Mellitus, Type 2; Humans; Immunosuppression Therapy; Male; Nephrectomy; Prednisolone; Pyelo | 2023 |
Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01.
Topics: Alleles; Autoantibodies; Biopsy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gluc | 2020 |
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; C | 2020 |
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
Topics: Adult; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Humans; Male; Middle Aged | 2020 |
More Than Meets the Eye: A Patient with Hand Swelling and Newly Diagnosed Diabetes Mellitus.
Topics: Aged; Amlodipine; Anemia; Antihypertensive Agents; Blood Sedimentation; C-Reactive Protein; Diabetes | 2021 |
HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepa | 2017 |
Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
Topics: Adult; Age Factors; Aged; Body Mass Index; Cyclosporine; Diabetes Mellitus, Type 2; Female; Glucocor | 2018 |
Rare diagnosis in a patient with diabetes with nephrotic proteinuria.
Topics: Amyloidosis; Biopsy; Diabetes Mellitus, Type 2; Glomerulonephritis; Glucocorticoids; Humans; Male; M | 2019 |
Dramatic Improvement of Glycemic Control by Promptly Starting Steroid Therapy at an Early Stage of Autoimmune Pancreatitis in a Subject with Type 2 Diabetes.
Topics: Aged; Autoimmune Pancreatitis; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedul | 2019 |
Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2013 |
Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Can | 2014 |
IgA-dominant postinfectious glomerulonephritis associated with Escherichia coli infection caused by cholangitis.
Topics: Aged; Biopsy; Cholangitis; Diabetes Mellitus, Type 2; Escherichia coli Infections; Glomerulonephriti | 2014 |
Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes.
Topics: Aged; Blood Pressure; Chemokine CCL2; Dexamethasone; Diabetes Mellitus, Type 2; Female; Glucocortico | 2015 |
Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; | 2015 |
Severe Insulin-resistant Diabetes due to Insulin Antibodies Associated with Eosinophilia.
Topics: Aged; Antibodies; Blood Glucose; Diabetes Mellitus, Type 2; Eosinophilia; Glucocorticoids; Humans; H | 2015 |
Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glucocorticoi | 2016 |
A discrepancy between plasma glycated albumin and HbA1c levels in a patient with steroid-induced diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucocorticoids; Glycated Hemoglobin; Glycate | 2016 |
[A man in his 40s with diabetes, enlarged lacrimal gland and kidney failure].
Topics: Adult; Autoimmune Diseases; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Immunoglobulin G; La | 2016 |
Posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hosp | 2008 |
[Complete resolution of insulin-dependent diabetes mellitus in a patient with autoimmune pancreatitis following treatment with corticosteroids].
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Hypoglycemic Agents; Insuli | 2010 |
Autoimmune pancreatitis. A rare cause of cholestasis.
Topics: Autoimmune Diseases; Cholestasis; Diabetes Complications; Diabetes Mellitus, Type 2; Diagnosis, Diff | 2011 |
Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Diabetes Mellitus, Type 2; Edema; Female; Graft vs Host Disease; Humans | 2012 |
[Neutrophilic dermatosis of the hands].
Topics: Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Edema; Female; Hand Dermatoses; Humans; Middle | 2011 |
Primary bone lymphoma of the shoulder.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2012 |
Hyperglycemia and methylprednisolone: comment on the article by den Uyl et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Hum | 2012 |
Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia.
Topics: Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose- | 2013 |
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
Topics: 3T3 Cells; Adipocytes; Animals; Biotransformation; Blood Glucose; Cell Differentiation; Cholic Acids | 2005 |
[Practical ambulatory therapy for multisystem atrophy and diabetes mellitus].
Topics: Aged; Ambulatory Care; Anti-Inflammatory Agents; Calcium; Diabetes Mellitus, Type 2; Female; Humans; | 2005 |
Diagnostic and therapeutic challenges. High grade fever and bronchitis.
Topics: 2-Aminopurine; Administration, Oral; Aged; Anti-Inflammatory Agents; Antiviral Agents; Atropine; Bro | 2006 |
[Dramatic deterioration after withdrawal of steroid therapy].
Topics: Addison Disease; Anti-Inflammatory Agents; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Diagnosis | 2006 |
Prognosis for Bell's palsy: a comparison of diabetic and nondiabetic patients.
Topics: Bell Palsy; Diabetes Mellitus, Type 2; Facial Nerve; Follow-Up Studies; Glucocorticoids; Glycated He | 2007 |
Infectious crystalline keratopathy following trabeculectomy and low-dose topical steroids.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Cornea; Corneal Opacity; Diabetes Mellitus, Ty | 1995 |
[Autoimmune hepatitis, autoimmune gastritis, hypergastrinemia and stomach carcinoid].
Topics: Autoimmune Diseases; Azathioprine; Carcinoid Tumor; Cholangiopancreatography, Endoscopic Retrograde; | 1995 |
Pemphigus vulgaris precipitated by glibenclamide therapy.
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Pseudomonal necrotizing enterocolitis in a patient with polymyositis.
Topics: Aged; Aspergillosis; Diabetes Mellitus, Type 2; Enterocolitis, Pseudomembranous; Female; Humans; Pol | 1996 |
Churg-Strauss syndrome associated with necrotizing crescentic glomerulonephritis in a diabetic patient.
Topics: Anti-Inflammatory Agents; Churg-Strauss Syndrome; Cyclophosphamide; Diabetes Mellitus, Type 2; Diabe | 1997 |
Delayed recovery of patients with Bell's palsy complicated by non-insulin-dependent diabetes mellitus and hypertension.
Topics: Adult; Diabetes Mellitus, Type 2; Facial Paralysis; Female; Humans; Hypertension; Male; Middle Aged; | 1998 |
A case of pyoderma gangrenosum on the stump of an amputated right leg.
Topics: Aged; Amputation Stumps; Amputation, Surgical; Anti-Inflammatory Agents; Arterial Occlusive Diseases | 2000 |
Polymyalgia rheumatica and type 2 diabetes mellitus complicated with electromyographic abnormalities that responded well to corticosteroid therapy.
Topics: Autoimmune Diseases; Blood Sedimentation; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Ne | 2000 |
A falling HbA1c is not necessarily an indicator of improving diabetes control.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Female; Flupenthixol; Glycated Hemoglobin; Hemoglobins; Hemol | 2001 |
Non-diabetic renal disease in patients with type 2 diabetes mellitus.
Topics: Adult; Age Distribution; Aged; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabe | 2001 |
[A case of epilepsia partialis continua associated with nonketotic hyperglycemia due to steroid-induced diabetes mellitus].
Topics: Diabetes Mellitus, Type 2; Epilepsies, Partial; Humans; Hyperglycemia; Male; Middle Aged; Prednisolo | 1987 |